Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.144
-0.156 (-12.02%)
Apr 28, 2026, 9:30 AM EST

Nuo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
55956624630
Upgrade
Market Cap Growth
32.00%44.81%169.36%-61.19%2071893.52%-99.98%
Upgrade
Enterprise Value
55956524600
Upgrade
Last Close Price
1.141.971.400.551.500.00
Upgrade
PS Ratio
16.7128.6448.0139.99558.56-
Upgrade
PB Ratio
-57.87-99.22127.5923.4228.610.00
Upgrade
P/TBV Ratio
--127.5923.4228.610.00
Upgrade
EV/Sales Ratio
16.5728.5247.6439.48536.08-
Upgrade
Debt / Equity Ratio
-0.10-0.100.320.250.15-
Upgrade
Net Debt / Equity Ratio
0.470.47-0.23-0.65-0.78-1.78
Upgrade
Net Debt / EBITDA Ratio
0.190.190.050.210.52-
Upgrade
Net Debt / FCF Ratio
0.400.400.050.210.4611.79
Upgrade
Asset Turnover
2.182.180.890.250.05-
Upgrade
Inventory Turnover
6.026.021.680.56--
Upgrade
Quick Ratio
0.850.850.921.753.572.10
Upgrade
Current Ratio
1.061.061.462.324.392.18
Upgrade
Return on Equity (ROE)
---299.28%-196.34%-212.57%-62.68%
Upgrade
Return on Assets (ROA)
-103.65%-103.65%-100.16%-80.41%-91.97%-6.96%
Upgrade
Return on Capital Employed (ROCE)
-466.60%-466.60%-402.20%-263.30%-135.70%-11.40%
Upgrade
Earnings Yield
-4.54%-2.65%-3.55%-13.03%-5.06%-2996.37%
Upgrade
FCF Yield
-2.06%-1.20%-3.64%-13.05%-6.01%-3964.14%
Upgrade
Buyback Yield / Dilution
-4.16%-4.16%-7.95%-5.19%-32.03%-10.93%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.